Literature DB >> 1558837

Induction of T-cell activation by oxidized low density lipoprotein.

J Frostegård1, R Wu, R Giscombe, G Holm, A K Lefvert, J Nilsson.   

Abstract

Oxidation and scavenger receptor-mediated uptake of low density lipoprotein (LDL) in intimal macrophages are believed to be key events in the development of atherosclerosis. We report here that oxidized LDL increases DNA synthesis, expression of HLA-DR, and interleukin-2 receptors in T cells. The stimulatory effect of oxidized LDL was not due to a direct effect on T cells but required the presence of monocytes. Oxidized LDL also stimulated the release of interleukin-1 beta from monocytes. The maximal effect of oxidized LDL on T-cell activation and interleukin-1 beta release occurred at a concentration of 1 micrograms/ml. Native LDL also had the capacity to activate T cells, although only at higher concentrations. The stimulatory effect of both native and oxidized LDL was inhibited by superoxide dismutase. Monocytes as well as T cells were found to have the ability to oxidize LDL, suggesting that the stimulatory effect of native LDL may arise as a result of LDL oxidation during incubation with monocytes and T cells. The results suggest that oxidized LDL may activate T cells in atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558837     DOI: 10.1161/01.atv.12.4.461

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  48 in total

Review 1.  Association of anticardiolipin antibodies with vascular injury: possible mechanisms.

Authors:  Y S Haviv
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.

Authors:  S Caspar-Bauguil; M Saadawi; A Negre-Salvayre; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus.

Authors:  Wen-Nan Huang; Tim K Tso; Hui-Yu Huang
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

4.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

5.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

6.  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.

Authors:  S Caspar-Bauguil; J Tkaczuk; M J Haure; M Durand; J Alcouffe; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

Review 7.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

Review 8.  Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors.

Authors:  Giuseppe Murdaca; Francesca Spanò; Paola Cagnati; Francesco Puppo
Journal:  Redox Rep       Date:  2013-05-10       Impact factor: 4.412

9.  Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality.

Authors:  A G Frostegård; X Hua; J Su; J J Carrero; O Heimbürger; P Bárány; P Stenvinkel; J Frostegård
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

10.  Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Ann-Charlotte Elkan; Niclas Håkansson; Johan Frostegård; Tommy Cederholm; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.